Evidence map›Paper›PMID 36483050›Full record

ArticleFrontiers in oncology2022

Use of multimodality imaging, histology, and treatment feasibility to characterize a transgenic

Luke R Jackson, Megan R Masi, Bryce M Selman, George E Sandusky, Hamideh Zarrinmayeh, Sudip K Das, Surendra Maharjan, Nian Wang, Qi-Huang Zheng, Karen E Pollok and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Luke R JacksonDepartment of Radiology and Imaging Sciences, Indiana University (IU) School of Medicine, Indianapolis, IN, United States.
Megan R MasiDepartment of Radiology and Imaging Sciences, Indiana University (IU) School of Medicine, Indianapolis, IN, United States.
Bryce M SelmanDepartment of Pathology and Laboratory Medicine, Indiana University (IU) School of Medicine, Indianapolis, IN, United States.
George E SanduskyDepartment of Pathology and Laboratory Medicine, Indiana University (IU) School of Medicine, Indianapolis, IN, United States.
Hamideh ZarrinmayehDepartment of Radiology and Imaging Sciences, Indiana University (IU) School of Medicine, Indianapolis, IN, United States.
Sudip K DasDepartment of Pharmaceutical Sciences, Butler University, Indianapolis, IN, United States.
Surendra MaharjanDepartment of Radiology and Imaging Sciences, Indiana University (IU) School of Medicine, Indianapolis, IN, United States.
Nian WangDepartment of Radiology and Imaging Sciences, Indiana University (IU) School of Medicine, Indianapolis, IN, United States.
Qi-Huang ZhengDepartment of Radiology and Imaging Sciences, Indiana University (IU) School of Medicine, Indianapolis, IN, United States.
Karen E PollokDepartment of Pediatrics, Indiana University (IU) School of Medicine, Indianapolis, IN, United States.
Scott E SnyderDepartment of Radiology and Imaging Sciences, Indiana University (IU) School of Medicine, Indianapolis, IN, United States.
Phillip Zhe SunDepartment of Radiology and Imaging Sciences, Emory School of Medicine, Atlanta, GA, United States.
Gary D HutchinsDepartment of Radiology and Imaging Sciences, Indiana University (IU) School of Medicine, Indianapolis, IN, United States.
Elizabeth R ButchDepartment of Radiology and Imaging Sciences, Indiana University (IU) School of Medicine, Indianapolis, IN, United States.
Michael C VeronesiDepartment of Radiology and Imaging Sciences, Indiana University (IU) School of Medicine, Indianapolis, IN, United States.
Indiana University – Purdue University Indianapolis · USButler University · USEmory and Henry College · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
NIH HHS P51 OD011132
6 · The paper itself

Abstract

Many drugs that show potential in animal models of glioblastoma (GBM) fail to translate to the clinic, contributing to a paucity of new therapeutic options. In addition, animal model development often includes histologic assessment, but multiparametric/multimodality imaging is rarely included despite increasing utilization in patient cancer management. This study developed an intracranial recurrent, drug-resistant, human-derived glioblastoma tumor in Sprague-Dawley

Indexed as

amide proton transfer (APT) imagingamino acid PETCEST MRIglioblastomahybrid PET/MRImagnetic resonance imaging (MRI)positron emission tomography (PET)

Identifiers

PMID36483050
PMCPMC9722958
OpenAlexW4309735297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.